228 related articles for article (PubMed ID: 22901764)
21. RhoA/ROCK pathway mediates p38 MAPK activation and morphological changes downstream of P2Y12/13 receptors in spinal microglia in neuropathic pain.
Tatsumi E; Yamanaka H; Kobayashi K; Yagi H; Sakagami M; Noguchi K
Glia; 2015 Feb; 63(2):216-28. PubMed ID: 25130721
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid receptor 2‑selective agonist JWH015 attenuates bone cancer pain through the amelioration of impaired autophagy flux induced by inflammatory mediators in the spinal cord.
Mao Y; Huang Y; Zhang Y; Wang C; Wu H; Tian X; Liu Y; Hou B; Liang Y; Rong H; Gu X; Ma Z
Mol Med Rep; 2019 Dec; 20(6):5100-5110. PubMed ID: 31661120
[TBL] [Abstract][Full Text] [Related]
23. The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB₂ receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy.
Deng L; Guindon J; Vemuri VK; Thakur GA; White FA; Makriyannis A; Hohmann AG
Mol Pain; 2012 Sep; 8():71. PubMed ID: 22998838
[TBL] [Abstract][Full Text] [Related]
24. Role of mitogen-activated protein kinase activation in injured and intact primary afferent neurons for mechanical and heat hypersensitivity after spinal nerve ligation.
Obata K; Yamanaka H; Kobayashi K; Dai Y; Mizushima T; Katsura H; Fukuoka T; Tokunaga A; Noguchi K
J Neurosci; 2004 Nov; 24(45):10211-22. PubMed ID: 15537893
[TBL] [Abstract][Full Text] [Related]
25. The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain.
Klauke AL; Racz I; Pradier B; Markert A; Zimmer AM; Gertsch J; Zimmer A
Eur Neuropsychopharmacol; 2014 Apr; 24(4):608-20. PubMed ID: 24210682
[TBL] [Abstract][Full Text] [Related]
26. Sigma-1 receptor-mediated increase in spinal p38 MAPK phosphorylation leads to the induction of mechanical allodynia in mice and neuropathic rats.
Moon JY; Roh DH; Yoon SY; Kang SY; Choi SR; Kwon SG; Choi HS; Han HJ; Beitz AJ; Lee JH
Exp Neurol; 2013 Sep; 247():383-91. PubMed ID: 23333567
[TBL] [Abstract][Full Text] [Related]
27. Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision.
Romero-Sandoval A; Eisenach JC
Anesthesiology; 2007 Apr; 106(4):787-94. PubMed ID: 17413917
[TBL] [Abstract][Full Text] [Related]
28. TRESK contributes to pain threshold changes by mediating apoptosis via MAPK pathway in the spinal cord.
Zhou J; Lin W; Chen H; Fan Y; Yang C
Neuroscience; 2016 Dec; 339():622-633. PubMed ID: 27789381
[TBL] [Abstract][Full Text] [Related]
29. Evidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative pain.
Alkaitis MS; Solorzano C; Landry RP; Piomelli D; DeLeo JA; Romero-Sandoval EA
PLoS One; 2010 May; 5(5):e10891. PubMed ID: 20531936
[TBL] [Abstract][Full Text] [Related]
30. Intrathecal administration of antisense oligonucleotide against p38α but not p38β MAP kinase isoform reduces neuropathic and postoperative pain and TLR4-induced pain in male mice.
Luo X; Fitzsimmons B; Mohan A; Zhang L; Terrando N; Kordasiewicz H; Ji RR
Brain Behav Immun; 2018 Aug; 72():34-44. PubMed ID: 29128611
[TBL] [Abstract][Full Text] [Related]
31. P2Y12 regulates microglia activation and excitatory synaptic transmission in spinal lamina II neurons during neuropathic pain in rodents.
Yu T; Zhang X; Shi H; Tian J; Sun L; Hu X; Cui W; Du D
Cell Death Dis; 2019 Feb; 10(3):165. PubMed ID: 30778044
[TBL] [Abstract][Full Text] [Related]
32. Bullatine A stimulates spinal microglial dynorphin A expression to produce anti-hypersensitivity in a variety of rat pain models.
Huang Q; Mao XF; Wu HY; Li TF; Sun ML; Liu H; Wang YX
J Neuroinflammation; 2016 Aug; 13(1):214. PubMed ID: 27577933
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of cytochrome P450c17 reduces spinal astrocyte activation in a mouse model of neuropathic pain via regulation of p38 MAPK phosphorylation.
Choi SR; Beitz AJ; Lee JH
Biomed Pharmacother; 2019 Oct; 118():109299. PubMed ID: 31387001
[TBL] [Abstract][Full Text] [Related]
34. Mitogen-activated protein kinase (MAPK) phosphatase-3 (MKP-3) displays a p-JNK-MAPK substrate preference in astrocytes in vitro.
Ndong C; Landry RP; Saha M; Romero-Sandoval EA
Neurosci Lett; 2014 Jul; 575():13-8. PubMed ID: 24861519
[TBL] [Abstract][Full Text] [Related]
35. The analgesic effects of triptolide in the bone cancer pain rats via inhibiting the upregulation of HDACs in spinal glial cells.
Hu XF; He XT; Zhou KX; Zhang C; Zhao WJ; Zhang T; Li JL; Deng JP; Dong YL
J Neuroinflammation; 2017 Nov; 14(1):213. PubMed ID: 29096654
[TBL] [Abstract][Full Text] [Related]
36. Ibudilast produces anti-allodynic effects at the persistent phase of peripheral or central neuropathic pain in rats: Different inhibitory mechanism on spinal microglia from minocycline and propentofylline.
Fujita M; Tamano R; Yoneda S; Omachi S; Yogo E; Rokushima M; Shinohara S; Sakaguchi G; Hasegawa M; Asaki T
Eur J Pharmacol; 2018 Aug; 833():263-274. PubMed ID: 29886243
[TBL] [Abstract][Full Text] [Related]
37. Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats.
Detloff MR; Fisher LC; McGaughy V; Longbrake EE; Popovich PG; Basso DM
Exp Neurol; 2008 Aug; 212(2):337-47. PubMed ID: 18511041
[TBL] [Abstract][Full Text] [Related]
38. Cynandione A attenuates neuropathic pain through p38β MAPK-mediated spinal microglial expression of β-endorphin.
Huang Q; Mao XF; Wu HY; Liu H; Sun ML; Wang X; Wang YX
Brain Behav Immun; 2017 May; 62():64-77. PubMed ID: 28189715
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-6 induces microglial CX3CR1 expression in the spinal cord after peripheral nerve injury through the activation of p38 MAPK.
Lee KM; Jeon SM; Cho HJ
Eur J Pain; 2010 Aug; 14(7):682.e1-12. PubMed ID: 19959384
[TBL] [Abstract][Full Text] [Related]
40. Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice.
Segat GC; Manjavachi MN; Matias DO; Passos GF; Freitas CS; Costa R; Calixto JB
Neuropharmacology; 2017 Oct; 125():207-219. PubMed ID: 28729222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
